FASLODEX



Trademark Coverage

No Class Specified

human pharmaceutical preparations and substances for [ prevention and/or ] treatment of cancer [ and/or disorders and diseases of endocrine system ]

Owners
Timeline
  • Feb 22
    2013
    Notice Of Acceptance Of SEC 8 & 9 Mailed
  • Feb 21
    2013
    Notice Of Acceptance Of SEC 8 & 9 E Mailed
  • Feb 21
    2013
    Registered And Renewed (Second Renewal 10 Yrs)
  • Feb 21
    2013
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • Feb 21
    2013
    Case Assigned To Post Registration Paralegal
  • Feb 01
    2013
    TEAS Section 8 & 9 Received
  • Jun 05
    2008
    Case File In TICRS
  • Jun 17
    2007
    Attorney Revoked And/Or Appointed
  • Jun 17
    2007
    TEAS Revoke/Appoint Attorney Received
  • Jun 16
    2003
    Registered And Renewed (First Renewal 10 Yrs)
  • Jun 16
    2003
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • May 04
    2003
    Registered Combined Section 8 (10 Yr) & SEC 9 Filed
  • Feb 04
    2003
    Registered Combined Section 8 (10 Yr) & SEC 9 Filed
  • Feb 26
    2003
    Paper Received
  • Feb 04
    2003
    Paper Received
  • May 28
    1998
    Registered SEC 8 (6 Yr) Accepted
  • Apr 02
    1998
    Registered SEC 8 (6 Yr) Filed
  • Feb 02
    1993
    Registered Principal Register
  • Dec 18
    1992
    Notice Of Allowance Cancelled
  • Sep 15
    1992
    NOA Mailed SOU Required From Applicant
  • Jun 23
    1992
    Published For Opposition
  • May 22
    1992
    Notice Of Publication
  • Dec 26
    1991
    Approved For PUB Principal Register
  • Dec 04
    1991
    Correspondence Received In Law Office
  • Nov 16
    1991
    Letter Of Suspension Mailed
  • Apr 10
    1991
    Letter Of Suspension Mailed
  • Mar 19
    1991
    Assigned To Examiner